Main settings
| 10 year return | 0 |
| 3 year return | 33.5 |
| 5 year return | 85.99 |
| Annual return | 47.71 |
| Asset size | Multi-Cap |
| Asset type | Equity |
| Average P/BV | 3.96 |
| Average P/E | 28.93 |
| Average P/S | 3.94 |
| Beta | 0.98 |
| Commission | 0.79 |
| Country | USA |
| Currency | usd |
| Div. yield | 0.14 |
| Focus | Health Care |
| Foundation date | 2014-12-16 |
| Full name | Virtus LifeSci Biotech Products ETF |
| ISIN code | US26923G2021 |
| ISO country | US |
| Index | LifeSci Biotechnology Products Index |
| Number of companies | 61 |
| Owner | Virtus |
| Region | United States |
| Region | U.S. |
| Strategy | Equal |
| Top 10 issuers, % | 26.26 |
| Website | link |
| segment | Equity: U.S. Biotechnology |
| Change per day | -0.97% (82.1748) |
| Change per week | +2.13% (79.679) |
| Change per month | +4.68% (77.735) |
| Change per 3 month | +11.48% (72.9967) |
| Change per half year | +20.87% (67.324) |
| Change per year | +47.71% (55.0904) |
| Change per year to date | +2.13% (79.679) |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
Similar ETF
Other ETFs from the Management Company
| Title | Class | Category | Commission | Annual return |
|
Virtus InfraCap U.S. Preferred Stock ETF
PFFA
|
Preferred Stock | 2.52 | 8.12 | |
|
InfraCap MLP ETF
AMZA
|
Equity | 2.18 | -5.14 | |
|
Virtus Seix Senior Loan ETF
SEIX
|
Bond | 0.62 | 0.99 | |
|
Virtus Terranova U.S. Quality Momentum ETF
JOET
|
Equity | 0.29 | 22.81 | |
|
Virtus Newfleet Multi-Sector Bond ETF
NFLT
|
Bond | 0.5 | 3.99 | |
|
Virtus Reaves Utilities ETF
UTES
|
Equity | 0.49 | 19.23 | |
|
InfraCap REIT Preferred ETF
PFFR
|
Preferred Stock | 0.45 | 3.1 | |
|
Virtus Private Credit Strategy ETF
VPC
|
Equity | 9.72 | -8.48 | |
|
Virtus Real Asset Income ETF
VRAI
|
Real Estate | 0.55 | 5.79 | |
|
Virtus LifeSci Biotech Clinical Trials ETF
BBC
|
Equity | 0.79 | 117.72 | |
|
Virtus Newfleet ABS/MBS ETF
VABS
|
Bond | 0.39 | 0.0791 | |
|
Virtus Duff & Phelps Clean Energy ETF
VCLN
|
Equity | 0.59 | 58.08 | |
|
Virtus WMC International Dividend ETF
VWID
|
Equity | 0.49 | 18.81 |
Description Virtus LifeSci Biotech Products ETF
BBP предлагает другой подход к инвестированию в биотехнологии, выбирая вручную фирмы, чьи ведущие препараты находятся на стадии разработки, или те фирмы, которые получили одобрение FDA на свое ведущее лекарство. Акции должны получать большую часть своих доходов от исследований и разработок и / или маркетинга и продажи новых лекарств или других терапевтических средств, используемых для лечения заболеваний человека. Фонд предлагается BioShares вместе с запущенным дочерним фондом BBC, который нацелен на биотехнологические компании на стадии клинических испытаний. Индекс восстанавливается каждые полгода.
Based on sources: porti.ru
